Dashboard
Manage Tickers

IMVIMV Inc


$ 0.00 (0 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.0E-6
-- x --
-- x --
-- - --
$ 0.00 - $ 0.50
220
na
na
$ -2.78
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
05/02/2023 15:00:40

hc-wainwright--co-downgrades-imv-to-neutral
HC Wainwright & Co. Downgrades IMV to Neutral
05/02/2023 10:16:42

HC Wainwright & Co. analyst Joseph Pantginis downgrades IMV (NASDAQ:IMV) from Buy to Neutral.

Core News & Articles
IMV Initiates Restructuring Proceedings Un...
05/01/2023 16:32:39

IMV Inc. (the "Company" or "IMV") (NASDAQ:IMV, TSX:IMV), a clinical-stage biopharmaceutical Company developing ...

imv-shares-were-halted-at-400-am-et-news-pending
IMV Shares Were Halted At 4:00 AM ET, News...
05/01/2023 08:51:46

why-bed-bath--beyond-shares-are-trading-lower-by-23-here-are-20-stocks-moving-premarket
Why Bed Bath & Beyond Shares Are Trading L...
04/26/2023 12:37:39

Gainers

Core News & Articles
IMV Receives Nasdaq Notification Regarding...
03/31/2023 20:21:38

IMV Inc. ("IMV" or the "Company") (NASDAQ:IMV, TSX:IMV), a clinical-stage company developing a portfolio of imm...

hc-wainwright--co-reiterates-buy-on-imv---1-for-10-reverse-stock
HC Wainwright & Co. Reiterates Buy on IMV ...
03/16/2023 16:38:29

HC Wainwright & Co. analyst Joseph Pantginis reiterates IMV (NASDAQ:IMV) with a Buy, 1-for-10 reverse stock

earnings-scheduled-for-march-15-2023
Earnings Scheduled For March 15, 2023
03/15/2023 08:41:03

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share...

imvs-earnings-a-preview
IMV's Earnings: A Preview
03/14/2023 18:02:47

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
03/07/2023 18:01:11

  On Tuesday, 93 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
02/24/2023 19:11:31

  On Friday, 135 companies reached new 52-week lows.

why-top-ships-are-trading-lower-by-45-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Top Ships Are Trading Lower By 45%? He...
02/14/2023 19:26:03

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to...

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
02/14/2023 15:58:39

  During Tuesday, 40 stocks hit new 52-week lows.

why-frequency-therapeutics-are-trading-lower-by-82-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Frequency Therapeutics Are Trading Low...
02/13/2023 19:12:02

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
02/13/2023 16:24:43

  On Monday, 42 companies hit new 52-week lows.

imv-stock-falls-after-interim-data-from-lead-candidate-in-blood-cancer-subtype
IMV Stock Falls After Interim Data From Le...
02/13/2023 15:29:26

hc-wainwright--co-reiterates-buy-on-imv-maintains-65-price-target
HC Wainwright & Co. Reiterates Buy on IMV,...
02/13/2023 14:50:57

HC Wainwright & Co. analyst Joseph Pantginis reiterates IMV (NASDAQ:IMV) with a Buy and maintains $65 price target.

imv-says-initial-results-showed-multiple-confirmed-complete-responses-observed-in-heavily-pre-treated-patients-no-adverse-safety-and-tolerability-signals-reported
IMV Says Initial Results Showed 'Multiple ...
02/13/2023 12:08:09

imv-presents-positive-initial-results-from-the-mvp-s-phase-2b-vitalize-trial
IMV Presents Positive Initial Results From...
02/13/2023 12:07:51

The company announced positive preliminary data from the VITALIZE Phase 2B trial evaluating its lead DPX product, maveropepimut...

imv-inc-announces-prelminary-data-from-vitalize-phase-2b-trial-says-early-analysis-reveals-clinically-meaningful-activity-in-refractory-dlbcl-patients
IMV Inc. Announces Prelminary Data From VI...
02/13/2023 12:07:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION